PET

Rumpke and Eastman join forces to expand recycling of PET waste

Retrieved on: 
Thursday, February 8, 2024

KINGSPORT, Tenn. and CINCINNATI, Ohio, Feb. 8,  2024 /PRNewswire/ -- Leading North American recycler, Rumpke Waste & Recycling (Rumpke) and molecular recycling pioneer Eastman , today announced a groundbreaking partnership to help address the global plastic waste crisis.

Key Points: 
  • KINGSPORT, Tenn. and CINCINNATI, Ohio, Feb. 8,  2024 /PRNewswire/ -- Leading North American recycler, Rumpke Waste & Recycling (Rumpke) and molecular recycling pioneer Eastman , today announced a groundbreaking partnership to help address the global plastic waste crisis.
  • Later this year, Rumpke will begin collecting and sorting hard-to-recycle and colored PET packaging waste, materials that are largely unaddressed in today's recycling ecosystem and will provide 100 percent of this waste stream as feedstock to Eastman's molecular recycling process.
  • Eastman will then turn this waste stream into virgin quality polyesters with its molecular recycling technology to be used across a range of packaging applications and to expand the circular economy for polyesters.
  • "Rumpke and Eastman are both committed to innovative approaches to reducing plastic waste through collaboration," said Brad Lich, Eastman executive vice president and chief commercial officer.

Mitsubishi Corporation, KDDI CORPORATION, Lawson, Inc. have entered into the Capital Business Partnership Agreement

Retrieved on: 
Tuesday, February 6, 2024

Lawson and KDDI will merge their real touchpoints (Lawson stores: approximately 14,600, au Style/au shop stores: approximately 2,200) to establish large real-store networks in Japan.

Key Points: 
  • Lawson and KDDI will merge their real touchpoints (Lawson stores: approximately 14,600, au Style/au shop stores: approximately 2,200) to establish large real-store networks in Japan.
  • This will enable Lawson to expand its store network and enhance its functionalities, aiming for further improvement in customer convenience.
  • - Developing services for KDDI and Lawson customers to provide good shopping deals, expanding customer visits to Lawson stores.
  • KDDI is expanding into a wide range of business areas including mobile telecommunications as core business, as well as banking, insurance, education, travel, and delivery services.

The brain is the most complicated object in the universe. This is the story of scientists’ quest to decode it – and read people’s minds

Retrieved on: 
Wednesday, February 7, 2024

This is the closest science has yet come to reading someone’s mind.

Key Points: 
  • This is the closest science has yet come to reading someone’s mind.
  • As Alexander Huth, the neuroscientist who co-led the research, told the New York Times:
    This isn’t just a language stimulus.
  • In the longer term, this could lead to wider public applications such as fitbit-style health monitors for the brain and brain-controlled smartphones.
  • On January 29, Elon Musk announced that his Neuralink tech startup had implanted a chip in a human brain for the first time.

Humanity’s greatest mapping challenge

  • By fully mapping the structure and function of a healthy human brain, we can determine with great precision what goes awry in diseases of the brain and mind.
  • Similar initiatives were launched in Europe in 2013 (the Human Brain Project) and China in 2016 (the China Brain Project).
  • This daunting endeavour may still take generations to complete – but the scientific ambition of mapping and reading people’s brains dates back more than two centuries.
  • With the world having been circumnavigated many times over, Antarctica discovered and much of the planet charted, humanity was ready for a new (and even more complicated) mapping challenge – the human brain.
  • In the 1860s, “locationist” views of how the brain worked made a comeback – though the scientists leading this research were keen to distinguish their theories from phrenology.
  • French anatomist Paul Broca discovered a region of the left hemisphere responsible for producing speech – thanks in part to his patient, Louis Victor Leborgne, who at age 30 lost the ability to say anything other than the syllable “tan”.
  • This approach depends on the findings of American physiologist John Fulton almost a century ago.
  • This stronger pulse of activity was not replicated by other sensory inputs, for example when smelling tobacco or vanilla.

The first clinical trial

  • The ultimate goal is wireless, non-invasive devices that help patients communicate and move with precision in the real world.
  • In 2004, BrainGate began the first clinical trial using BCIs to enable patients with impaired motor systems (including spinal cord injuries, brainstem infarctions, locked-in syndrome and muscular dystrophy) control a computer cursor with their thoughts.
  • The team is working with academics from different backgrounds who have been engaged in projects aimed at tackling societal and scientific challenges.
  • Patient MN, a quadriplegic since being stabbed in the neck in 2001, was the trial’s first patient.
  • In addition, brain activity was linked to the patient’s prosthetic hand and robotic arm, enabling rudimentary actions including grasping and transporting an object.
  • Also in 2017, BrainGate clinical trials reported the first evidence that BCIs could be used to help patients regain movement of their own limbs by bypassing the damaged portion of the spinal cord.

A new era of ‘mind reading’ technology

  • But having been primarily envisaged as a tool for diagnostics and monitoring, it is now also a core element of the latest neural communication and prosthetic devices.
  • Despite being behaviourally non-responsive and minimally conscious, these patients were able to answer yes-or-no questions just by using their minds.
  • Now, a decade on, the HuthLab research at the University of Texas constitutes a paradigmatic shift in the evolution of communication-enabling neuroimaging systems.
  • Whereas the brain’s capacity to produce motor intentions is shared across species, the ability to produce and perceive language is uniquely human.
  • The disadvantage of fMRI is that it can only take slow measurements of brain signals (typically, one brain volume every two or three seconds).
  • They demonstrated that the system could be used not only to decode semantic content entertained through auditive perception, but also through visual perception.
  • Importantly, they also explicitly addressed the potential threat to a person’s mental privacy posed by this kind of technology.
  • We take very seriously the concerns that it could be used for bad purposes and have worked to avoid that.

The ethical implications are immense

  • Losing the ability to communicate is a deep cut to one’s sense of self.
  • The ethical implications of providing access to such data to scientific and corporate entities are potentially immense.
  • For example, Parkinson’s disease, a neurodegenerative disease that affects movement, is co-morbid with dementia, which affects the ability to reason and think clearly.
  • In line with this approach, Chile was the first country that adopted legislation to address the risks inherent to neurotechnology.
  • One of the cornerstones of ethical research is the principle of informed consent.
  • The growing availability of neurotechnology in a commercial context that is generally subject to far less regulation only amplifies these ethical and legal concerns.
  • We are at an early stage of technological development and as we begin to uncover the great potential of BCI, both for therapeutic applications and beyond, the need to consider these ethical questions and their implications for legal action becomes more pressing.

Decoding our neuro future

  • By the middle of 2021, the total investment in neurotechnology companies amounted to just over US$33 billion (around £26 million).
  • The implant is said to include 1,024 electrodes, yet is only slightly larger than the diameter of a red blood cell.
  • The Kernel Flow, for example, is a commercially available, wearable headset that uses fNRIS technology to monitor brain activity.
  • The dawn of a new era of brain-computer interfaces should be treated with great care and great respect – in acknowledgement of its immense potential to both help, and harm, our future generations.


For you: more from our Insights series:
Unlocking new clues to how dementia and Alzheimer’s work in the brain – Uncharted Brain podcast series

Freedom of thought is being threatened by states, big tech and even ourselves. Here’s what we can do to protect it

OCD is so much more than handwashing or tidying. As a historian with the disorder, here’s what I’ve learned

Noise in the brain enables us to make extraordinary leaps of imagination. It could transform the power of computers too

To hear about new Insights articles, join the hundreds of thousands of people who value The Conversation’s evidence-based news. Subscribe to our newsletter.
Stephanie Sheir received funding from the EPSRC (grant number EP/V026518/1). Timo Istace receives funding from Fonds Wetenschappelijk Onderzoek Vlaanderen. Nicholas J. Kelley does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

InventHelp Inventor Develops Assistive Device for Pets Climbing into Vehicles (DAL-402)

Retrieved on: 
Friday, February 2, 2024

My design would be easy to set up and transport.”

Key Points: 
  • My design would be easy to set up and transport.”
    The patent-pending invention provides a device to help dogs into and out of vehicles.
  • In doing so, it offers an alternative to lifting the dog.
  • As a result, it reduces the impact on a dog’s joints and it increases comfort and convenience.
  • 22-DAL-402, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext.

Celebrating Innocycle’s Environmental Milestones: Closed-Loop Recycling Service Makes Significant Impact

Retrieved on: 
Tuesday, January 30, 2024

Innovive is proud to announce major environmental milestones achieved by the Closed-Loop Recycling program operated by its sister company, Innocycle.

Key Points: 
  • Innovive is proud to announce major environmental milestones achieved by the Closed-Loop Recycling program operated by its sister company, Innocycle.
  • "With the support of our customers and an industry committed to reducing its environmental impact, the Closed-Loop Recycling program has achieved remarkable results."
  • The Closed-Loop Recycling Service allows customers to keep their operations simple, safe, and science-focused.
  • "From inception, Innovive has focused on reducing the environmental impact of our products and operations.

SK chemicals Targets the US Medical Packaging Market with Circular Recycling Solution

Retrieved on: 
Thursday, February 1, 2024

SEONGNAM, South Korea, Feb. 1, 2024 /PRNewswire/ -- SK chemicals aims to enter the medical packaging market by unveiling a circular recycling solution at the upcoming Medical Design & Manufacturing West 2024 (MD&M) exhibition, held in Anaheim, USA from the 6th to the 8th of this month.

Key Points: 
  • - Participates in the US's top medical device exhibition MD&M West 2024, unveiling circular recycling solution
    - Collaborates with medical device packaging company Pacur, LLC to seize the growing demand for recycled plastics in the US medical device industry
    SEONGNAM, South Korea, Feb. 1, 2024 /PRNewswire/ -- SK chemicals aims to enter the medical packaging market by unveiling a circular recycling solution at the upcoming Medical Design & Manufacturing West 2024 (MD&M) exhibition, held in Anaheim, USA from the 6th to the 8th of this month.
  • At the exhibition, SK chemicals will showcase not only its conventional polyester used in medical items such as PPE(Personal Protective Equipment) and medical Device Packaging but also materials applying circular recycling technology, such as SKYPET CR and ECOTRIA CR.
  • Pacur will exhibit products incorporating SK Chemical's materials, and detailed explanations about these materials will be provided at SK Chemical's booth.
  • The medical equipment market has been growing along with the increasing incidence of chronic diseases, consequently driving the growth of the medical packaging market.

SK chemicals Targets the US Medical Packaging Market with Circular Recycling Solution

Retrieved on: 
Thursday, February 1, 2024

SEONGNAM, South Korea, Feb. 1, 2024 /PRNewswire/ -- SK chemicals aims to enter the medical packaging market by unveiling a circular recycling solution at the upcoming Medical Design & Manufacturing West 2024 (MD&M) exhibition, held in Anaheim, USA from the 6th to the 8th of this month.

Key Points: 
  • - Participates in the US's top medical device exhibition MD&M West 2024, unveiling circular recycling solution
    - Collaborates with medical device packaging company Pacur, LLC to seize the growing demand for recycled plastics in the US medical device industry
    SEONGNAM, South Korea, Feb. 1, 2024 /PRNewswire/ -- SK chemicals aims to enter the medical packaging market by unveiling a circular recycling solution at the upcoming Medical Design & Manufacturing West 2024 (MD&M) exhibition, held in Anaheim, USA from the 6th to the 8th of this month.
  • At the exhibition, SK chemicals will showcase not only its conventional polyester used in medical items such as PPE(Personal Protective Equipment) and medical Device Packaging but also materials applying circular recycling technology, such as SKYPET CR and ECOTRIA CR.
  • Pacur will exhibit products incorporating SK Chemical's materials, and detailed explanations about these materials will be provided at SK Chemical's booth.
  • The medical equipment market has been growing along with the increasing incidence of chronic diseases, consequently driving the growth of the medical packaging market.

Mass-Vac, Inc. Introduces MV Multi-Trap® Vacuum Inlet Trap that Extends the Pump Life for Plastic Extruders

Retrieved on: 
Tuesday, January 30, 2024

NORTH BILLERICA, Mass., Jan. 30, 2024 /PRNewswire-PRWeb/ -- Mass-Vac, Inc. has introduced a high-capacity vacuum inlet trap that helps prevent pump failure due to the volatile materials created by PET, HDPE, PVC, LDPE, PP, PS and other plastic extrusion processes.

Key Points: 
  • Capable of replacing several of the traditional trapping methods including knock-out pots with one compact canister, the MV Multi-Trap® Vacuum Inlet Trap is suitable for all types of plastics extruders.
  • The MV Multi-Trap® Vacuum Inlet Trap features 304 stainless steel construction and consists of a baffle section plus two or three stages, optional cooling, and parallel banks of stainless steel gauze mesh filters to condense and collect volatile vapors from the extruder vent.
  • Capable of replacing several of the traditional trapping methods with one compact canister, the MV Multi-Trap® Vacuum Inlet Trap is offered in 10", 12", and 16" dia.
  • The MV Multi-Trap® Vacuum Inlet Trap is priced from $2,680(list); depending upon size and configuration.

EQS-News: Krones intends to expand its portfolio into injection molding with the imminent acquisition of Netstal

Retrieved on: 
Tuesday, January 30, 2024

Krones is close to sign an agreement regarding the acquisition of 100% of Netstal Maschinen AG (Netstal) from KraussMaffei.

Key Points: 
  • Krones is close to sign an agreement regarding the acquisition of 100% of Netstal Maschinen AG (Netstal) from KraussMaffei.
  • The company is a technological leader in its markets and has already been a strategic partner of Krones in the past.
  • In the 2023 fiscal year, Netstal generated with a workforce of more than 500 employees revenue of more than EUR 200 million.
  • Netstal will retain its business responsibility within Krones, while benefitting from the international set-up and scale of Krones.

Loop Industries and Bormioli Pharma Unveil an Innovative Pharmaceutical Packaging Bottle Manufactured with 100% Recycled Virgin Quality Loop PET Resin at Pharmapack 2024

Retrieved on: 
Wednesday, January 24, 2024

Bormioli Pharma tested Loop(TM) PET resin in its packaging, commissioning to independent third parties' additional analysis to verify extractables levels with different solutions, also taking in consideration the worst-case scenario.

Key Points: 
  • Bormioli Pharma tested Loop(TM) PET resin in its packaging, commissioning to independent third parties' additional analysis to verify extractables levels with different solutions, also taking in consideration the worst-case scenario.
  • "Through this collaboration with Loop we're strengthening our role as a solid, quality and reliable partner for the pharmaceutical industry" stated Andrea Lodetti, CEO of Bormioli Pharma.
  • Daniel Solomita, Founder and CEO of Loop Industries, commented "Through our collaboration with Bormioli Pharma, we have developed an innovative pharmaceutical packaging solution manufactured from 100% recycled virgin quality Loop(TM) PET resin.
  • 1 Results from an extractables study conducted by an independent, external lab and performed on bottles manufactured with Loop(TM) PET resin using different simulating solutions.